Nano-X Imaging Ltd. NNOX

What this company does

Nanox develops the multi-source Nanox.ARC, a 3D tomosynthesis imaging system that has received two 510(k) clearances from the FDA and remains subject to regulatory clearance and approval in other jurisdictions. Deployment of the systems runs through direct sales and commercial collaborations, with approximately 36 systems in various stages of deployment. Nanox.MARKETPLACE, acquired from MDWEB in November 2021, connects imaging facilities with radiologists and lets radiologists supply, and customers obtain, remote interpretations of imaging data. Teleradiology services are supplied to approximately 100 customers representing approximately 200 facilities, with images allocated to radiologists in the network according to their area of specialization. Manufacture of the MEMs X-ray chips began at the company's fabrication facility in Korea. The X-ray source technology has its roots in field emission display work: in 2011 the predecessor company acquired certain non-display related know-how from FET Japan Inc., and members of that technical team joined the company.

Written from the business description in Nano-X Imaging Ltd.'s annual report to the U.S. Securities and Exchange Commission, filed 30 April 2026. Every sentence was checked against that document before publication.